Biocracked
Longevity Metabolism Peptides Research Supplements Trending: supplements clinical trial longevity nad+ nootropics
Approach 4, conceptual metaphor, in palette D, bold color field. A single AA-style cylindrical battery, shown as a real physical object with a matte metal casing, stands upright at the center of a saturated tomato-red seamless paper backdrop. Its top half is bright and glossy, while the lower half is scuffed and dull. A thin, crisp line of electric green liquid light fills the clear gauge window along its side, stopping about three-quarters of the way up. Three smaller, identical dead batteries lie tipped over in the foreground, slightly out of focus, to suggest the rival compounds. The camera sits at a low three-quarter angle with a shallow depth of field. A hard, warm key light from the upper left casts a sharp, long shadow across the red surface. The mood is punchy and skeptical: one cell charged, the others spent.
Supplements

NMN vs NR vs NADH: Siji Nambah Ketahanan, Ora Ana Sing Bisa Ngatasi Kelelahan

Nova Chen · · 4 min read
#meta analysis #nmn #nad+ #endurance #nicotinamide riboside #fatigue #nadh

Sampeyan nganggo booster NAD+ amarga krasa lemes. Analisis jaringan meta anyar nuduhaké yèn iki dadi siji‑sijine perkara sing ora duwe perbaikan konsisten.

Studi iki, sing dipublikasikaké ing Frontiers in Nutrition déning Gao lan kancané saka Beijing Sport University, mbandhingaké prekursor NAD+ langsung ing macem‑macem jinis lelah. Asilé nuduhaké yèn suplemen iki nduwèni efek sing béda‑bèda, lan ora ana sing jelas marakaké wong krasa luwih sithik lemes.

Studi: Apa Sing Tenanan Ditindakake

Tim riset nindakake tinjauan sistematis lan jaringan meta‑analisis miturut pandhuan PRISMA‑NMA lan ndhaptar ing PROSPERO (CRD420251237193). Jaringan meta‑analisis ngidini para peneliti ngbandhingaké perlakuan sanajan mung sithik uji sing dibandhingaké langsung.

  • Kalebu: 27 studi (25 uji coba terkontrol acak lan 2 studi quasi‑eksperimental)
  • Peserta: 1.599 wong diwasa total
  • Kompaun: nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), NADH lan nicotinamide (NAM)
  • Domain asil: rasa lelehan sing dipersepsèkaké, kinerja kognitif, kinerja olahraga (daya tahan lan kekuatan), kualitas urip (QoL) lan turu

Asil dilaporaké minangka beda rata standar (SMD), ing ngendi angka luwih gedhé nuduhaké efek luwih kuwat, lan kompaun dipérang rangking nganggo skor SUCRA. Penulis nyatakake ora ana konflik kapentingan komersial utawa finansial.

Peringkat, Domain demi Domain

Penulis nyatakake yèn jawaban kanggo "prekursor endi sing paling apik?" gumantung marang tujuan sing dipengini.

Daya Tahan: NMN nguwasani, lan efeké nambah karo dosis

NMN nuduhaké perbaikan daya tahan sing gumantung dosis:

  • Dosis menengah: SMD 0.66 (95% CI 0.09–1.23)
  • Dosis tinggi: SMD 1.02 (95% CI 0.43–1.60)

Miturut patokan konvensional, SMD cedhak 1 dianggep efek gedhé, dadi iki asil panutan. Interval kapercayané amba, utamané ing dosis menengah sing wates ngisoré cedhak karo nol.

Kognisi: NADH dadi sing utama, nanging ana cathetan penting

NADH ngasilaké perbaikan kognisi paling kuat (SMD 1.50, 95% CI 0.82–2.19), utamané ing kelompok sing nduwèni gangguan kognitif. Penulis nyebutaké yèn temuan iki sensitif marang pengaruh studi. Ing praktek, mbusak siji utawa sawetara uji coba bisa nyuda utawa malah ngowahi asil kasebut. Iki sinyal sing menjanjikan, nanging durung final, lan luwih relevan kanggo wong sing wis ngadhepi gangguan kognitif, dudu kanggo wong sehat sing kepengin ningkataké kemampuan mental.

Kualitas Urip (QoL): Kenaikan moderat, utama saka NMN

QoL nambah kanthi moderat, dipimpin mayoritas dening NMN:

  • Dosis tinggi: SMD 0.56 (95% CI 0.14–0.98)
  • Dosis rendah: SMD 0.45 (95% CI 0.11–0.78)

Kaloro dosis iki béda ora adoh, mula manfaat iki ora nuduhaké pola dosis‑respon sing cetha kaya ing daya tahan.

Kekuatan: Ora ana owahan

Kekuatan neuromuskular ora berubah. Apa sing NMN lakokaké kanggo daya tahan, ora marakaké wong dadi luwih kuat.

Kejutan: Lelah lan Turu Ora Nganti Perubahan

Temuan kunci yaiku asil negatif. Ora ana prekursor sing sacara signifikan ningkataké rasa lemes utawa kualitas turu.

Booster NAD+ umumé dipasaraké minangka suplemen energi, lan disfungsi energi sing gumantung NAD+ dianggep mekanisme utama lelah. Nanging ing data gabungan, wong ora nglaporaké rasa lemes sing luwih sithik, sanajan daya tahan sing diukur nambah karo NMN.

Penulis ngandharake lelah minangka multidimensi, kanthi komponen kognitif, fisik, lan subyektif. Suplemen bisa ngowahi siji komponen tanpa ngganti sing liyané. Data iki nuduhaké prekursor NAD+ bisa ngowahi apa sing awak bisa dilakokaké ing tugas daya tahan, nanging ora ngowahi rasa lemes saben dina.

Abstrak ora nerangaké sababé, mula saben pangerten mung spekulasi. Skala lelah subyektif bisa wae berisik. Uji coba bisa wae ngrekrut wong sing ora banget lemes. Akeh studi cilik. Utawa suplemené tenan ora nduwèni pangaruh marang rasa lemes sing dialami.

Kepiye Karo NR?

NR kamungkinan prekursor sing paling asring dibahas, nanging abstrak ora nyebutaké keuntungan cetha kanggo NR ing domain apa wae. Iki ora ateges NR ora ana gunané. Kesimpulan khusus ing abstrak ngarahaké marang NMN kanggo daya tahan lan QoL, lan NADH kanggo kognisi. Perbandingan rinci NR lan NAM kudu dibukak ing artikel lengkap.

Watesan Sing Perlu Sampeyan Ngerti

  • Studi heterogen, akèh sing cilik. Populasi, dosis, durasi, lan ukuran asil sing béda nambah ketidakpastian.
  • Kategorisasi dosis ditemtokaké déning penulis. Abstrak ora nyedhiyakake ambang miligram sing cetha kanggo "rendah", "menengah", lan "tinggi", mula label iku ora ateges dosis tartamtu. Kanggo konteks umum, uji coba NMN ing manungsa biasané ana ing kisaran 250–1.200 mg/s dina.
  • Hasil kognisi NADH rapuh lan konsentrasi ing grup kanthi gangguan kognitif.
  • Desain campuran. Loro saka 27 studi iku quasi‑eksperimental, ora random.
  • Perbandingan ora langsung. Jaringan meta‑analisis maringi peringkat kanthi inferensi, dadi rangkingé ora padha karo uji coba gedhé sing dibandhingaké langsung.

Takeaway Praktis

Dosis: Bukti paling kuat yaiku pola dosis‑respon kanggo NMN ing daya tahan, karo efek luwih gedhé ing kategori dosis dhuwur. Abstrak ora nyebutaké ambang miligram, mula priksa artikel lengkap utawa uji coba individu sadurunge milih dosis, lan aja nganggep luwih akeh iku otomatis aman.

Wektu: Abstrak ora nyebutaké wektu panggunaan (sawijining dina, sadurungé olah raga, utawa sawise mangan), mula ora ana saran berbasis bukti kanggo wektu panggunaan.

Sapa sing cocog:

  • Wong diwasa sing kepengin ningkataké performa daya tahan, ing ngendi NMN nuduhaké sinyal paling cetha.
  • Wong sing pengin peningkatan kualitas urip sing moderat, kanthi ekspektasi realistis.
  • Klinisi utawa pasien sing nliti NADH kanggo gangguan kognisi, minangka pilihan riset tahap awal.

Sapa sing kudu skeptis utawa ngindari:

  • Sapa wae sing tuku booster NAD+ kanggo ngurangi rasa lemes utawa supaya turune luwih apik, amarga ora ana prekursor sing ningkataké loro kuwi.
  • Sapa wae sing ngarep‑arep nambah kekuatan, amarga kekuatan ora berubah.
  • Wong sing lagi ngandhut, nyusoni, utawa nduwèni kondisi medis utawa obat-obatan, sing kuduné takon dhisik karo dokter (pituduh umum, dudu asil studi iki).

Kesimpulan

Analisis iki ndhukung narasi sing luwih wajar tinimbang pemasaran. NMN nduwèni kasus paling apik kanggo ningkataké daya tahan, kanthi bonus QoL sing moderat. NADH nuduhaké sinyal kognisi sing tentative ing populasi sing gangguan. Ora ana prekursor sing ndadékaké perubahan ketok ing rasa lemes utawa turu. Penulis nyaranaké pendekatan presisi sing nyocogaké kompaun, dosis, lan populasi karo asil sing pancen dikarepake.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

Share XFacebookLinkedInRedditWhatsApp
NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach 3, the human outcome, in palette D, a bold color field. Close-up of an older adult's bare upper arm, seen from a slightly high three-quarter angle, with a blood pressure cuff wrapped snugly above the elbow. The cuff is matte graphite grey with a coiled rubber tube trailing out of frame. The arm shows real skin texture, freckles and fine creases, and the face is out of frame. The backdrop is a saturated, flat tomato-red wall. A small electric green LED glows on the cuff's digital monitor at the edge of the frame, with its display blurred and unreadable. Soft, even studio light comes from the left, with gentle shadows and no blue cast. Shallow depth of field keeps the cuff edge and skin pores sharp. The mood is calm, clinical and quietly hopeful.
supplements

NMN lan Tekanan Darah: Ringkesan 10 Uji Gabungan, Penurunan Terbanyak ing Umur >60

BY NOVA CHEN ·

Meta‑analisis anyar ing *Nutrients* nggabungake 10 uji acak NMN kanggo ndeleng apa suplemen iki bisa mengaruhi tekanan darah. Saka 349 peserta, NMN nurunake tekanan diastolik kira‑kira 2,15 mmHg, dene perubahan sistolik ora signifikan. Ing wong umur 60 taun utawa luwih, tekanan sistolik mudhun kira‑kira 3,94 mmHg. Nanging ukuran sampel cilik lan model analisis sing prasaja, mula bukti isih dhasar lan kudu dipriksa maneh. NMN ora bisa diganti obat tekanan darah.
Approach: the human outcome. Palette: natural. A tight, low-angle shot of an elderly person's hands gripping a smooth wooden cane at the top of a sunlit garden path. The hands are weathered and slightly tremulous, with visible veins and thin, spotted skin. Behind them, the blurred figure of a seated older man in a cardigan is just recognizable, with his face out of frame. Warm late-morning daylight comes from the side and picks out the grain of the wood and the texture of the skin. The background is soft green foliage and a gravel path in shallow depth of field. The tones are plant greens, honeyed wood and natural skin. A single fresh leaf in vivid electric green sits in the lower foreground. The mood is quiet, honest and reflective, and it suggests fragility without drama.
longevity

Lansia Lemah Duwe NAD+ Darah Sing Luwih Endhek. Apa Artine Kanggo NMN/NR

BY HELIX WARD ·

Sebuah studi GeroScience sing nganalisa 529 wong Jepang umur 65 taun utawa luwih nemokake yen wong tuwa sing frail nduwe kadar NAD+ ing whole‑blood sing kira‑kira 13 % luwih endhek saben kenaikan 1 µmol/L. Nanging asil iki saka studi cross‑sectional, jumlah kasus frail mung 32 lan selisih mediané mung 24 vs 25 µmol/L. Sawise disetel karo hematokrit, hubungané ora signifikan. Artikel iki nerangake apa makna data iki, kenapa ora dadi bukti NMN utawa NR nyegah frail, lan apa sing kudu digatekake yen sampeyan kepengin nyoba prekursor NAD+.
Approach: conceptual metaphor. Palette: bold color field. Subject: two identical brushed-steel analog pressure gauges side by side on a saturated mustard-yellow seamless backdrop, shot straight-on at eye level with a 85mm lens. The left gauge's needle swings down toward the low end, the right gauge's needle swings up into the high end, so they point in opposite directions. The dials are blank, with only unlabeled tick marks. A tiny electric green glass indicator lamp glows on the left gauge's rim. Lighting is a large softbox from the upper left, giving crisp highlights on the chrome bezels and short, clean shadows on the yellow surface. Shallow depth of field softens the background edges. Mood: playful, precise and tense, a visual argument between two opposing results.
longevity

NR Ngloworake Umur Epigenetik Otot, HIIT Nglawanake

BY HELIX WARD ·

NR lan HIIT loro‑loro kerep dipromosekaké minangka cara kanggo njaga otot tetep enom, nanging artikel anyar ing *Aging Cell* nemokaké yèn loro‑loro iki narik jam epigenetik menyang arah sing bertentangan. Lima wulan suplemen nicotinamide riboside (NR) ana hubungane karo pelambatan percepatan umur epigenetik otot, utamané ing jam PCHannum, MEAT, lan DunedinPACE. HIIT malah ngasilaké pola kebalik, nambah kecepatan penuaan ing jam DunedinPACE. Hubungan iki bisa uga medharake peran mitokondria, amarga owah‑owahan kandungan mitokondria otot korélasi karo owah‑owahan percepatan umur adhedhasar MEAT.
Approach: Macro science, with a Bold color field palette. Extreme close-up microscopy-style image of a single microglial cell with fine, branching processes, rendered with the real texture of fluorescence-stained tissue: translucent, slightly granular cell body, delicate ramified arms reaching across the frame. Shot from straight overhead through a microscope objective with shallow depth of field, so the outer branches soften into blur. The cell is a luminous, warm ivory-white with a few small electric green (#00e676) points of light along its branches. Behind it is a saturated, even magenta backdrop with subtle tissue grain. Lighting is crisp and backlit, with gentle glow around the edges and no harsh shadows. The mood is curious and precise, with a quiet sense of renewal. No text or labels.
longevity

Studi Tikus: NR Ngganti Sel Otak Sing Penuaan Dadi Kondisi Luwih Enom

BY NOVA CHEN ·

Ing studi GeroScience paling anyar, tikus umur 22 wulan sing diwènèhi nicotinamide riboside (NR) sajrone wolung minggu nuduhaké asil memori lan bangunan sarang sing luwih apik, sarta sel imun otaké dadi luwih mirip sel tikus enom. Iki mung studi ing tikus, ora ateges manfaaté padha kanggo manungsa. Dosae 400 mg/kg adoh banget saka dosis sing diombé wong, lan artikel iki mung nyebutaké tikus jantan. Ing ngisor iki apa sing owah ing mikroglia, watesan studi, lan apa tegese temuan iki kanggo pangguna NR.

This page is available in

English العربيةবাংলাČeštinaDeutschEspañolفارسیFrançaisHausaहिन्दीHrvatskiBahasa IndonesiaItaliano日本語Basa Jawa한국어NederlandsਪੰਜਾਬੀPolskiPortuguêsRomânăРусскийSrpskiTürkçeУкраїнськаTiếng Việt中文